Literature DB >> 8225751

Estimation of vaccine effectiveness using the screening method.

C P Farrington1.   

Abstract

The screening method provides a simple and rapid way of estimating vaccine effectiveness. The paper discusses the validity of the screening method with particular reference to bias and precision. Methods for correcting confounding, adjusting for covariates and over-dispersion, and deriving confidence limits are discussed in a modelling framework. The methods are illustrated using data on measles and pertussis vaccines.

Mesh:

Substances:

Year:  1993        PMID: 8225751     DOI: 10.1093/ije/22.4.742

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  57 in total

Review 1.  Vaccine trials.

Authors:  C P Farrington; E Miller
Journal:  Mol Biotechnol       Date:  2001-01       Impact factor: 2.695

2.  An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada.

Authors:  Shelley L Deeks; Gillian H Lim; Mary Anne Simpson; Louise Gagné; Jonathan Gubbay; Erik Kristjanson; Cecilia Fung; Natasha S Crowcroft
Journal:  CMAJ       Date:  2011-05-16       Impact factor: 8.262

3.  Early estimates of 2014/15 seasonal influenza vaccine effectiveness in preventing influenza-like illness in general practice using the screening method in France.

Authors:  Cécile Souty; Thierry Blanchon; Isabelle Bonmarin; Daniel Lévy-Bruhl; Sylvie Behillil; Vincent Enouf; Martine Valette; Maude Bouscambert; Clément Turbelin; Lisandru Capai; Victoire Roussel; Thomas Hanslik; Alessandra Falchi
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Effectiveness and impact of a single-dose vaccine against chickenpox in the community of Madrid between 2001 and 2015.

Authors:  Pello Latasa; Angel Gil de Miguel; Maria Dolores Barranco Ordoñez; Inmaculada Rodero Garduño; Juan Carlos Sanz Moreno; María Ordobás Gavín; María Esteban Vasallo; Macarena Garrido-Estepa; Luis García-Comas
Journal:  Hum Vaccin Immunother       Date:  2018-06-22       Impact factor: 3.452

5.  Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity.

Authors:  Helen Campbell; Nick Andrews; Ray Borrow; Caroline Trotter; Elizabeth Miller
Journal:  Clin Vaccine Immunol       Date:  2010-03-10

6.  Vaccine waning and mumps re-emergence in the United States.

Authors:  Joseph A Lewnard; Yonatan H Grad
Journal:  Sci Transl Med       Date:  2018-03-21       Impact factor: 17.956

7.  Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data.

Authors:  H E de Melker; J F Schellekens; S E Neppelenbroek; F R Mooi; H C Rümke; M A Conyn-van Spaendonck
Journal:  Emerg Infect Dis       Date:  2000 Jul-Aug       Impact factor: 6.883

8.  Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.

Authors:  Cheryl Cohen; Joanne M White; Emma J Savage; Judith R Glynn; Yoon Choi; Nick Andrews; David Brown; Mary E Ramsay
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

Review 9.  Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs.

Authors:  Caroline L Trotter; Martin C J Maiden
Journal:  Expert Rev Vaccines       Date:  2009-07       Impact factor: 5.217

10.  Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England.

Authors:  Nick Andrews; Ray Borrow; Elizabeth Miller
Journal:  Clin Diagn Lab Immunol       Date:  2003-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.